Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures

被引:21
作者
Ganesh, J. Saravana [1 ]
Rogers, Chris A. [1 ]
Banner, Nicholas R. [1 ]
Bonser, Robert S. [1 ]
机构
[1] Royal Coll Surgeons England, Clin Effect Unit, London WC2A 3PN, England
关键词
D O I
10.1016/j.jtcvs.2007.05.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite 50 years of lung preservation research, the optimal preservation technique is undefined. Using data from a national cohort, we investigated outcomes with different preservation methods after adult lung transplantation. Methods: Early (30- day), late ( 30- day to 3-year), and overall ( 3-year) mortalities, adjusted for differences in donor and recipient characteristics, were compared by using Cox regression. Intensive care unit length of stay and the number of rejection episodes were secondary outcomes. Results: Six hundred eighty-one eligible lung transplantations between July 1995 and June 2003 were preserved with Euro-Collins solution ( n = 284), blood albumin ( n = 139), core cooling ( n = 107), or low potassium dextran solution ( n = 151). There was significantly increased use of low potassium dextran solution over time ( P <.001). Unadjusted 3-year survival was similar across the groups ( P =.72), with the highest 3-year survival in the low potassium dextran group ( 62%; 95% confidence interval, 51%-72%) and the lowest in the blood albumin group (49%; 95% confidence interval, 39%- 58%). Risk-adjusted early ( P =. 70), late ( P =. 27), and overall ( P =. 72) survival was similar across the groups and was not affected by ischemic time. Freedom from death caused by primary graft dysfunction was again highest in the low potassium dextran group ( 95%; 95% confidence interval, 90%-98%) and lowest in the blood albumin group ( 91%; 95% confidence interval, 85%-95%). There was no difference in intensive care unit length of stay. An increased incidence of rejection was apparent with increasing ischemic time ( P =.067). Conclusion: The methods of lung preservation in current use do not seem to affect early or midterm survival after transplantation, but increasing ischemic time might predispose to increased rejection.
引用
收藏
页码:1313 / 1321
页数:9
相关论文
共 31 条
[1]  
ADACHI H, 1987, J HEART TRANSPLANT, V6, P253
[2]   Perfadex for clinical lung procurement: Is it an advance? [J].
Aziz, TM ;
Pillay, TM ;
Corris, PA ;
Forty, J ;
Hilton, CJ ;
Hasan, A ;
Dark, JH .
ANNALS OF THORACIC SURGERY, 2003, 75 (03) :990-995
[3]  
CAMERON AC, 1996, ANAL COUNT DATA
[4]   Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation [J].
Christie, JD ;
Carby, M ;
Bag, R ;
Corris, P ;
Hertz, M ;
Weill, D .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (10) :1454-1459
[5]  
COX DR, 1972, J R STAT SOC B, V34, P187
[6]  
de Perrot Marc, 2004, Semin Thorac Cardiovasc Surg, V16, P300, DOI 10.1053/j.semtcvs.2004.09.012
[7]   Low-potassium dextran preservation solution improves lung function after human lung transplantation [J].
Fischer, S ;
Matte-Martyn, A ;
de Perrot, M ;
Waddell, TK ;
Sekine, Y ;
Hutcheon, M ;
Keshavjee, S .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 121 (03) :594-596
[8]   Improvements in lung preservation:: 3 years' experience with a low-potassium dextran solution [J].
Gámez, P ;
Córdoba, M ;
Millán, I ;
Madrigal, L ;
Alfageme, F ;
Alvarez, R ;
Núñez, I ;
Varela, A .
ARCHIVOS DE BRONCONEUMOLOGIA, 2005, 41 (01) :16-19
[9]   Outcome of heart-lung and bilateral sequential lung transplantation for cystic fibrosis: a UK national study [J].
Ganesh, JS ;
Rogers, CA ;
Bonser, RS ;
Banner, NR .
EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (06) :964-969
[10]  
HAKIM M, 1988, J THORAC CARDIOV SUR, V95, P474